Meta Imaging Solutions

  
Chrysalis breast displacement system with optional shielding 
Meta Imaging Solutions (Booth 3005) is featuring CT dose reduction technology, the patent-pending Chrysalis Breast Displacement System that decreases breast radiation dose while doing CT coronary angiography and CT of the abdomen. In contrast to other dose-reduction methods, the breasts are physically displaced out of the imaging plane and secured with the Chrysalis device. A randomized trial showed median dose reductions of 88 percent in the peri-areolar region and 95 percent in the upper quadrants while at the same time showing improved image quality in patients with large breasts, the company says. The device is constructed of soft, padded vinyl to encircle the patient. There are four components that may be inter-connected to fit to all patient sizes. Optional external shielding can be accurately placed out of the imaging plane by means of fiducial markers on the Chrysalis and secured to the device by Velcro.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.